Invesco heads into its Q2 earnings print — scheduled for July 28 — with short sellers quietly adding exposure and options traders showing the most defensive positioning in weeks, even as the stock notches a solid five-day gain.
The short-side story deserves attention here. Short interest has climbed 14% over the past month to 4.1% of the free float, with the bulk of that rebuilding happening since late June. The week-on-week rise of 5.5% is particularly notable — shorts added roughly 1.3 million shares between July 6 and July 10 before trimming fractionally into the close. Cost to borrow remains low at 0.46%, and availability is extremely loose at nearly 4,800% — meaning there are roughly 48 shares available to borrow for every one already lent out. There is no mechanical squeeze pressure here; the rebuilding reflects a deliberate directional bet, not a trapped position.
Options positioning reinforces the cautious lean. The put/call ratio has climbed to 0.18 — well above its 20-day average of 0.14 — putting the reading about 1.5 standard deviations above recent norms. That is far from a panic print (the 52-week high is 0.50), but the direction of travel over the past fortnight is clear: demand for downside protection has been rising steadily since late June, roughly coinciding with the short interest rebuild. Both signals are pointing the same way.
The Street, by contrast, is incrementally more constructive. Barclays raised its target from $26 to $31 on July 14, keeping an Equal-Weight rating. Evercore ISI lifted to $32 earlier in the week. The consensus mean target sits at $31.33, roughly 9% above the current price of $28.73. RBC's Outperform reiteration at $31 and TD Cowen's Buy with a $33 target represent the bullish anchor. The recent positive note on Invesco's stronger-than-expected Q2 asset flows — $12.2 billion in net inflows across ETFs and active strategies — gives the bulls a concrete fundamental hook. Valuation multiples are undemanding: the stock trades at roughly 9.4x earnings and below book value at 0.82x, with EV/EBITDA near 7.4x. Factor scores are middling, with a 71st-percentile reading on 12-month forward EPS growth the standout positive, offset by softer near-term EPS momentum in the 40th percentile.
The insider flow from early July adds a mild counterpoint. The CFO sold $1.4 million on July 2, a Managing Director sold $4.2 million, and a Senior Managing Director sold $700k — all at $27.01. The 90-day net shares figure is marginally positive at roughly 234,000 shares, heavily influenced by equity awards rather than open-market buying. The sells are not alarming in isolation, but the cluster — three insiders exiting on the same day, two weeks before a scheduled earnings release — is worth noting alongside the short rebuild. Peer context is mixed: CG and BX each gained around 3% on the week, ahead of Invesco's 4.9% move, while TROW fell 3.4%, reflecting the uneven sentiment across asset managers.
The July 28 print is the obvious catalyst to watch. Recent earnings reactions have been benign — the last two prints saw barely any same-day move, with five-day drifts of 4-5% to the upside. Whether the market is positioning for a deviation from that pattern, or simply hedging ahead of a known event date, is what the options and short data will continue to reveal between now and the release.
See the live data behind this article on ORTEX.
Open IVZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
